000 01497 a2200409 4500
005 20250516125947.0
264 0 _c20131104
008 201311s 0 0 eng d
022 _a1420-9071
024 7 _a10.1007/s00018-012-1246-4
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSalem, Mohammad
245 0 0 _aMuramyl dipeptide responsive pathways in Crohn's disease: from NOD2 and beyond.
_h[electronic resource]
260 _bCellular and molecular life sciences : CMLS
_cSep 2013
300 _a3391-404 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
650 0 4 _aAcetylmuramyl-Alanyl-Isoglutamine
_xmetabolism
650 0 4 _aAnimals
650 0 4 _aAutophagy
650 0 4 _aBiological Transport
650 0 4 _aCrohn Disease
_xmetabolism
650 0 4 _aHumans
650 0 4 _aImmune System
650 0 4 _aInflammation
650 0 4 _aNod2 Signaling Adaptor Protein
_xmetabolism
650 0 4 _aPaneth Cells
_xmetabolism
650 0 4 _aPeptidoglycan
_xmetabolism
650 0 4 _aProtein Structure, Tertiary
650 0 4 _aSignal Transduction
650 0 4 _aT-Lymphocytes
_xcytology
650 0 4 _aToll-Like Receptors
_xmetabolism
700 1 _aSeidelin, Jakob Benedict
700 1 _aRogler, Gerhard
700 1 _aNielsen, Ole Haagen
773 0 _tCellular and molecular life sciences : CMLS
_gvol. 70
_gno. 18
_gp. 3391-404
856 4 0 _uhttps://doi.org/10.1007/s00018-012-1246-4
_zAvailable from publisher's website
999 _c22380383
_d22380383